Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Intravenous Haloperidol and Ondansetron Administered Intraoperatively in Reducing the Incidence of Postoperative Nausea and Vomiting (PONV) in Patients Undergoing Regional Anesthesia With Subarachnoid Block (RA-SAB)

NCT07087925 is registered in ClinicalTrials.gov with Rully Riyandika as lead sponsor.

NCT NCT07087925
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07087925 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Intravenous Haloperidol and Ondansetron Administered Intraoperatively in Reducing the Incidence of Postoperative Nausea and Vomiting (PONV) in Patients Undergoing Regional Anesthesia With Subarachnoid Block (RA-SAB)
Lead sponsor
Rully Riyandika
Phase
Not applicable
Overall status
Completed
Start date
January 15, 2025
Completion date
May 15, 2025
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

postoperative nausea and vomiting (ponv), spinal anesthesia, subarachnoid block